ETM

ETEM is a biochemical.

Setmelanotide (BIM-22493) is a selective agonist of melanocortin 4 receptor (MC4R)(human and rat MC4R with EC50s of 0.27 nM and 0.28 nM, respectively).

Setmelanotide Acetate(920014-72-8 free base) (RM-493 Acetate) is a selective agonist of melanocortin 4 receptor (MC4R)(human and rat MC4R with EC50s of 0.27 nM and 0.28 nM, respectively).

7ETMC is a selective Human Cytochrome P450s 1A1 and 1A2 inhibitor. 7ETMC showed IC50s of 0.46 μM and 0.50 μM for P450s 1A1 and 1A2 in the first six minutes, respectively, and did not show any inhibition activity for P450s 2A6 and 2B1 even at the dose of 5

ETMTC is a inhibitor of inflammatory cell adhesion molecules (cams)

Bedinvetmab (ZTS-00508841), a canine monoclonal antibody (mAb) designed to target nerve growth factor (NGF), prevents NGF from interacting with its receptors, tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR). This compound is utilized in the research of managing osteoarthritis pain in dogs [1] [2].

Lokivetmab, an Anti-Canine IL31 Recombinant Antibody, is a monoclonal antibody targeting canine IL-31, utilized in research related to atopic dermatitis (AD) in dogs [1].

Quetmolimab is a humanized monoclonal antibody targeting chemokine ligand 1 (CX3CL1) that can be used to study rheumatoid arthritis.

Blontuvetmab (AT 004), a caninized CD20 monoclonal antibody, is utilized in the study of Canine B-cell lymphoma [1].

Cirevetmab (ZTS-00521426), a caninized monoclonal antibody targeting Canis lupus familiaris TGFB1, is classified as an immunoglobulin G2-kappa. It functions as an immunomodulator [1].

Gilvetmab, a potent caninized anti-PD-1 monoclonal antibody, effectively inhibits the interaction between PD-1 and its ligand PDL-1 [1].

Ranevetmab (NV-01), a caninized anti-nerve growth factor (anti-NGF) monoclonal antibody (mAb), is utilized in research for alleviating pain associated with degenerative joint disease (DJD) in canines.

Relfovetmab is an anti-NGF monoclonal antibody (mAb) [1].

Anivovetmab (KIND-030), an IgG2 type monoclonal antibody targeting the VP2 protein (parvovirus major capsid), offers a potential research avenue for canine parvovirus infection.

Frunevetmab (NV-02), a felinized monoclonal antibody targeting nerve growth factor (NGF), exhibits a high affinity with a dissociation constant (Kd) of 20 pM and has been demonstrated to effectively mitigate osteoarthritis (OA) pain in cats [1] [2].

Izenivetmab (ZTS-00075623) is a caninized IgG2κ monoclonal antibody targeting NGFB [1].

Dovanvetmab (ZTS-00521505) is an IgG1-κ monoclonal antibody targeting feline interleukin 31 (Felcat IL31), primarily produced in Chinese Hamster Ovary (CHO) cells [1].

Tirnovetmab (KIND-016), an antibody, is utilized for experimental research purposes.

Tamtuvetmab (AT-005), a caninised version of blontuvetmab targeting CD52, enhances progression-free survival (PFS) and demonstrates in vivo efficacy for treating naïve T-cell lymphoma (LSA) in dogs. The compound has received veterinary approval [1] [2].

Betmidin is a natural product for research related to life sciences. The catalog number is TN6459 and the CAS number is 35589-22-1.